PITYRIASIS RUBRA PILARIS Clinical Trial
Official title:
Cosentyx (Secukinumab) for the Treatment of Adult Onset Pityriasis Rubra Pilaris: A Single Arm, Open-label Exploratory Trial
The primary objective of this study is to assess the potential effectiveness of Cosentyx in the treatment of adult-onset Pityriasis Rubra Pilaris or PRP.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03975153 -
Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
|
Phase 2 | |
Completed |
NCT03485976 -
Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
|
Phase 2 | |
Not yet recruiting |
NCT06444399 -
Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris
|
Phase 2 | |
Terminated |
NCT00815633 -
A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
|
Phase 4 |